GM26579
Fibroblast from Skin, Flank
Description:
MYOPATHY, MYOFIBRILLAR, 13, WITH RIMMED VACUOLES; MFM13
HEAT-SHOCK 22-KD PROTEIN 8; HSPB8
RIMMED VACUOLAR MYOPATHY
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases
PIGI Consented Sample |
|
Biopsy Source
|
Flank
|
|
Cell Type
|
Fibroblast
|
|
Tissue Type
|
Skin
|
|
Transformant
|
Untransformed
|
|
Sample Source
|
Fibroblast from Skin, Flank
|
|
Race
|
White
|
|
Ethnicity
|
Not Hispanic/Latino
|
|
Country of Origin
|
USA
|
|
Family Member
|
5
|
|
Family History
|
N
|
|
Relation to Proband
|
uncle
|
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| PDL at Freeze |
5.62 |
| Passage Frozen |
7 |
| |
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
| |
| Gene |
HSPB8 |
| Chromosomal Location |
12q24.23 |
| Allelic Variant 1 |
p.P173Sfs*43; MYOPATHY, MYOFIBRILLAR, 13, WITH RIMMED VACUOLES; MFM13 |
| Identified Mutation |
c.515dupC (p.P173Sfs*43) |
| Remarks |
Clinically affected; distal myopathy, generalized; muscle biopsy indicated inclusion body myopathy; co-segregation analysis results and confirmation by automated Sanger sequencing revealed a maternally inherited heterozygous mutation in the HSPB8 gene: c.515dupC (p.P173Sfs*43) in exon CDS 3; positive family history: this mutation is also present in the affected nephew (lymph GM26095, fibro GM26096) and affected sister (lymph GM26097, fibro GM26098); heterozygous variants of uncertain significance (VUS) that are present in both the affected son and affected brother are: CCDC78 c.986T>C (p.I329T), MUSK c.43C>A (p.L15M), and TRIM32 c.1223G>A (p.R408H); at-risk half-sister (GM26100-lymph); assistive device: wheelchair; pedigree and family history in PMID 31403083. |
| Al-Tahan S, Weiss L, Yu H, Tang S, Saporta M, Vihola A, Mozaffar T, Udd B, Kimonis V, New family with HSPB 8-associated autosomal dominant rimmed vacuolar myopathy Neurology Genetics5:e349 2018 |
| PubMed ID: 31403083 |
| Passage Frozen |
7 |
| Split Ratio |
1:2 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Percent O2 |
3% |
| Medium |
Eagles Minimum Essential Medium with Earle's salts:Dulbecco's modified MEM with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not inactivated |
| Supplement |
- |
|